Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 22:2020:2509875.
doi: 10.1155/2020/2509875. eCollection 2020.

Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia

Affiliations

Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia

Ginenus Fekadu et al. Cardiovasc Ther. .

Abstract

Introduction: Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes. Several studies conducted in different hospitals revealed a high incidence of inappropriate prescription of beta-blockers among hospitalized patients. Therefore, it is important to identify inappropriate beta-blocker prescribing since they may increase the risk of hospitalizations. Despite this, there was no study conducted related to drug use evaluation of beta-blockers in Nedjo general hospital (NGH). Thus, this study was aimed at assessing the use evaluation of beta-blockers in medical wards of NGH.

Methods: A retrospective cross-sectional study was conducted at medical wards of NGH from January 1, 2016, to December 31, 2017.

Results: Out of the total of 149 medical record of patients that contains beta-blockers, 84 (56.37%) were males and about one-third (31.54%) of the patients ages were between 41 and 50 years. Propranolol was the most commonly prescribed beta-blocker (62.76%), and 94.56% of beta-blockers were prescribed with correct indication. There were about 51%, 46.31%, 64.43%, and 46.98% of beta-blockers prescribed with the correct dose, duration, frequency, and route of administration, respectively. Regarding the routes of administration, 70 (46.98%) of them were prescribed with the correct route. Most drugs interacting were propranolol with cimetidine 26 (68.42%), and the most frequent condition for which beta-blockers were prescribed was hypertension (32.89%).

Conclusion: Overall, there was an inappropriate use of beta-blockers in terms of dosage and durations. So, prescribers of NGH should strictly adhere to the national treatment guideline when prescribing medications. Additionally, drug information centers have proved useful and effective in promoting rational drug use. Hence, it should be recommended for general use.

PubMed Disclaimer

Conflict of interest statement

The authors declare that no conflicts of interest exist.

Similar articles

References

    1. World Health Organization. WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy 2000-2003. Geneva: World Health Organization; 2000.
    1. Ross-Degnan D., Laing R., Quick J., et al. A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs. Social science & medicine. 1992;35(11):1329–1341. doi: 10.1016/0277-9536(92)90037-Q. - DOI - PubMed
    1. Le Grand A., Hogerzeil H. V., Haaijer-Ruskamp F. M. Intervention research in rational use of drugs: a review. Health policy and planning. 1999;14(2):89–102. doi: 10.1093/heapol/14.2.89. - DOI - PubMed
    1. Wong M. C. S., Wang H. H. X., Jiang J. Y., Leeder S., Griffiths S. M. Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong. Asia Pacific family medicine. 2011;10(1):p. 10. doi: 10.1186/1447-056X-10-10. - DOI - PMC - PubMed
    1. Morgan T. Hypertension in the Asian Pacific region: the problem and the solution. Journal of hypertension. 2008;26(9):1883–1885. doi: 10.1097/HJH.0b013e32830a976e. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources